10-Q: AMJ Global Technology Reports Q3 2024 Results, Shows Net Loss but Gains in Revenue Sharing and Software Assets

AMJ Global Technology reported a net loss for the third quarter of 2024, but saw some revenue from a new revenue sharing agreement and acquired software assets.

Summary

• AMJ Global Technology reported a net loss of $50,825 for the three months ended August 31, 2024, compared to a net loss of $14,550 for the same period in 2023.
• The company's operating expenses for the quarter were $50,833, primarily due to management compensation of $35,764.
• For the nine months ended August 31, 2024, the net loss was $47,484, a significant decrease from the $790,503 loss in the same period of 2023.
• The company generated $8 in revenue from a revenue sharing agreement with a related party.
• AMJ Global Technology acquired an 8% interest in database software for $3,371 and a Medicare contracts asset for $337.
• The company's total assets were $7,559, while total liabilities were $161,021, resulting in a working capital deficiency of $157,170.
• The company had 107,782,190 shares of common stock outstanding as of October 22, 2024.

Sentiment

Score: 3

Explanation: The document reveals significant financial challenges, a going concern issue, and reliance on related parties, despite some positive developments in revenue sharing and asset acquisition. The overall sentiment is negative due to the company's precarious financial position.

Positives

• The company's net loss decreased significantly year-over-year for the nine-month period.
• The company has started generating revenue through a revenue sharing agreement.
• The acquisition of software and technology assets could provide future value.
• The company has secured a revenue sharing agreement related to Medicare enrollees and insurance sales.

Negatives

• The company continues to operate at a loss.
• The company has a significant working capital deficiency of $157,170.
• The company's cash balance is very low at $229.
• The company is heavily reliant on related party transactions for funding and revenue.
• The company's disclosure controls and procedures were deemed not effective.

Risks

• The company has a going concern opinion from its auditor, indicating substantial doubt about its ability to continue as a going concern.
• The company is dependent on related party advances and the sale of common stock for funding.
• The company may not be successful in raising additional funding.
• The company's reliance on related party transactions poses a risk.
• The company's disclosure controls and procedures are not effective, which could lead to inaccurate financial reporting.

Future Outlook

The company intends to fund operations through debt and/or equity financing arrangements and is evaluating opportunities in the wholistic health industry, revenue sharing, and software assets. The company plans to seek additional financing in a private equity offering.

Management Comments

• Management believes the company's focus on the intersection of technology and wholistic health treatments is a promising area.
• Management acknowledges the company's reliance on related party advances and the sale of common stock for funding.
• Management states that the company is in the process of securing working capital from investors.

Industry Context

The company's focus on healthcare technology and AI-driven database solutions aligns with current industry trends, but its financial struggles and reliance on related parties are significant challenges. The company is attempting to leverage AI and quantum computing performance through a specialized database, which is a growing area of interest in the tech industry.

Comparison to Industry Standards

• AMJ Global Technology's financial performance is significantly below industry standards for technology companies, particularly those in the software and healthcare sectors.
• The company's lack of substantial revenue and reliance on related party transactions is not typical of established technology companies.
• Compared to companies like Oracle or SAP, which have established revenue streams and diverse customer bases, AMJ Global Technology is in a very early stage of development and faces significant financial challenges.
• The company's focus on a niche market of wholistic health treatments for athletes is not a common business model, making direct comparisons difficult.
• The company's acquisition of an 8% interest in a database software is similar to early-stage investments made by venture capital firms, but the company's financial position is much weaker than typical venture-backed startups.

Related Party Transactions

• The company has significant related party transactions, including revenue sharing, advances, and management fees.
• The company entered into a revenue sharing agreement with a company controlled by a related party.
• The company received advances from AMJ Global Entertainment LLC, a related party controlled by the company's CEO.
• The company issued shares of common stock to related parties for compensation, services, and settlement of debt.

Stakeholder Impact

• Shareholders face significant risk due to the company's financial instability and going concern issue.
• Employees may be impacted by the company's financial challenges and potential need for restructuring.
• Customers and suppliers may be affected by the company's ability to continue operations.
• Creditors face the risk of non-payment due to the company's financial difficulties.

Next Steps

• The company plans to seek additional financing through a private equity offering.
• The company will continue to evaluate opportunities in the wholistic health industry, revenue sharing, and software assets.
• The company will need to improve its financial position and address the going concern issue.

Key Dates

Keywords

financial results, revenue sharing, software acquisition, net loss, related party transactions, going concern, working capital, healthcare technology, Medicare, database software